C12N 2500/70
Undefined extracts
C12N2500/70 (Undefined extracts) appears on 569 US grants and 993 published applications in this corpus.
Search patents in C12N- Granted patents
- 569
- Published applications
- 993
- Assignees
- 667
- Inventors
- 2,265
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 6 | 0 |
| 1985 | 4 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 6 | 0 |
| 1992 | 8 | 0 |
| 1993 | 1 | 0 |
| 1994 | 11 | 0 |
| 1995 | 4 | 0 |
| 1996 | 8 | 0 |
| 1997 | 13 | 0 |
| 1998 | 12 | 0 |
| 1999 | 10 | 0 |
| 2000 | 3 | 0 |
| 2001 | 6 | 2 |
| 2002 | 5 | 9 |
| 2003 | 7 | 13 |
| 2004 | 3 | 21 |
| 2005 | 7 | 20 |
| 2006 | 7 | 27 |
| 2007 | 3 | 22 |
| 2008 | 3 | 23 |
| 2009 | 10 | 25 |
| 2010 | 11 | 30 |
| 2011 | 13 | 40 |
| 2012 | 15 | 34 |
| 2013 | 21 | 30 |
| 2014 | 21 | 37 |
| 2015 | 28 | 53 |
| 2016 | 27 | 56 |
| 2017 | 31 | 49 |
| 2018 | 35 | 47 |
| 2019 | 32 | 52 |
| 2020 | 25 | 43 |
| 2021 | 19 | 58 |
| 2022 | 23 | 52 |
| 2023 | 22 | 69 |
| 2024 | 25 | 82 |
| 2025 | 49 | 57 |
| 2026 | 26 | 42 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Composition for enhancing reprogramming efficiency from somatic cell to induced pluripotent stem cell, comprising mTOR activator, and method for enhancing reprogramming efficiency by using same6 Oct 2026US 12,753,394 B2Korea University Research and Business Foundation
- Method for manufacturing mitochondria-rich plasma22 Sep 2026US 12,741,068 B2Taiwan Mitochondrion Applied Technology Co., Ltd.
- Application of alkali-tolerant microbial bacteria PDC-1 and its in-situ remediation of organic contaminated soil in mining areas22 Sep 2026US 12,742,148 B2Chinese Research Academy of Environmental Sciences
- Cellulose constructs based on gas vesicles and bacterial cellulose15 Sep 2026US 12,735,674 B1
- Culture broth for gram-positive bacteria8 Sep 2026US 12,729,366 B2Quantamatrix Inc.
- Production of a probiotic composition8 Oct 2026US 2026/0306558 A1Blis Technologies Limited
- Pluripotent stem cell that can be isolated from body tissue1 Oct 2026US 2026/0297512 A1MuseCell Innovations Pte. Ltd.
- Single b-cell cultivation method24 Sep 2026US 2026/0285949 A1Hoffmann-La Roche Inc.
- Animal cell proliferation promoter, animal cell culture medium, method for culturing animal cells, and method for promoting proliferation of animal cells3 Sep 2026US 2026/0258098 A1Fuji Oil Holdings Inc.
- Process for preparation of human umbilical cord blood plasma and culture media for tissue regeneration27 Aug 2026US 2026/0250637 A1Iceta - Instituto De CiêNcias, Tecnologias E Agroambiente Da Universidade Do Porto
Most cited
By later US patents
- Serum-free cell culture medium and process for making same430US 4,560,655 AImmunex Corporation · 1985
- Reconstituted basement membrane complex with biological activity212US 4,829,000 AThe United States of America, as represented by the Secretary, Department of Health and Human Services · 1989
- Mammalian neural crest stem cells206US 5,589,376 ACalifornia Institute of Technology · 1996
- Method for culturing Chinese hamster ovary cells186US 5,633,162 AGlaxo Wellcome Inc. · 1997
- Mammalian multipotent neural stem cells159US 5,849,553 ACalifornia Institute of Technology · 1998